Unknown PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT03620292

Fluorescence Image Guided Surgery in Cholangiocarcinoma (COUGAR)

Cholangiocarcinoma Detection Using an Intraoperative Fluorescence Image Guided Approach With Bevacizumab-IRDye 800CW

Sponsor: University Medical Center Groningen

Interventions Bevacizumab-IRDye800CW near infrared (NIR) fluorescence imaging

Updated 8 times since 2018 Last updated: Apr 27, 2021 Started: Apr 1, 2019 Primary completion: Dec 1, 2021 Completion: Dec 1, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Hilar Cholangiocarcinoma and is currently ongoing. University Medical Center Groningen leads this study, which shows 8 recorded versions since 2019 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1/PHASE2

Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
May 2023 — Jul 2024 [monthly]

Unknown Status PHASE1_PHASE2

Status: Recruiting → Unknown Status
May 2021 — May 2023 [monthly]

Recruiting PHASE1_PHASE2
Jan 2021 — May 2021 [monthly]

Recruiting PHASE1_PHASE2

▶ Show 3 earlier versions

Nov 2019 — Jan 2021 [monthly]

Recruiting PHASE1_PHASE2
Nov 2018 — Nov 2019 [monthly]

Recruiting PHASE1_PHASE2

Status: Not Yet Recruiting → Recruiting
Sep 2018 — Nov 2018 [monthly]

Not Yet Recruiting PHASE1_PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Medical Center Groningen

Data source: University Medical Center Groningen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Groningen, Netherlands